Science Current Events | Science News | Brightsurf.com
 

Recent Survival Current Events

Recent Survival current events and Survival news articles. The latest Survival stories, articles, research, discoveries, current news and events from Brightsurf.
Sort By: Survival Current Events (Best Match) | Most Viewed Survival Current Events

NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1. View News Article (2014-10-01)


Docetaxel or pemetrexed with cisplatin achieve comparable outcomes in non-squamous Lu Ca
The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival, although docetaxel was associated with more frequent adverse events. View News Article (2014-09-29)


IMPRESS trial data on continuing tyrosine kinase inhibitor therapy after resistance development in lung cancer reported
Patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in addition to chemotherapy, a phase III trial presented at the ESMO 2014 Congress has shown. View News Article (2014-09-29)


Pertuzumab adds 16 months survival benefit to trastuzumab and chemo treatment for HER2-positive breast cancer
Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal. View News Article (2014-09-29)


Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid. View News Article (2014-09-29)


New data on combination treatments for melanoma
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.  View News Article (2014-09-29)


Calming down immune cells could hold key to melanoma treatment
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.  View News Article (2014-09-25)


The viability of premature babies is minimal at 22 weeks' gestation
A new study analyses the survival rates in Spain of newborns with a gestational age under 26 weeks. The results show that survival under 23 weeks is 'exceptional', although other factors such as birth weight and sex also have an influence. View News Article (2014-09-19)


The Lancet: Some lung cancer patients could live longer when treated
Treating advanced small-cell lung cancer (SCLC) with thoracic (or chest) radiation therapy in addition to standard treatment significantly prolongs long-term survival and reduces cancer recurrence in the chest by almost 50%. View News Article (2014-09-15)


Lady baboons with guy pals live longer
Numerous studies have linked social interaction to improved health and survival in humans, and new research confirms that the same is true for baboons.  View News Article (2014-09-10)

Sort By: Survival Current Events (Best Match) | Most Viewed Survival Current Events
© 2014 BrightSurf.com